Home › Funds › LBP AM SA › BNTX

LBP AM SA position in BNTX

BIONTECH SE · Health Care

LBP AM SA reported holding 329,270 shares of BNTX (BIONTECH SE) in its Q3 2026 13F filing — a position valued at US$32.4M, representing 0.29% of its reported portfolio and ranking #47 among its reported holdings. LBP AM SA has disclosed BNTX holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

Latest position (Q3 2026)329.27K sh
Reported value held$32.37M
Portfolio Weight0.29%
First reportedQ3 2024
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How LBP AM SA's BNTX position evolved

LBP AM SA first disclosed a stake in BNTX in Q3 2024 at 247,833 shares (US$29.4M). The position peaked in Q2 2026 at 388,498 shares, worth US$36.1M. Across 9 filings, LBP AM SA increased the stake 6 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 329,270 shares valued at US$32.4M — a reduction of -59,228 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2024 247.83K $29.44M New
Q4 2024 252.92K $28.82M Add
Q1 2025 305.22K $27.79M Add
Q2 2025 305.47K $32.52M Hold
Q3 2025 353.33K $34.85M Add
Q4 2025 368.58K $35.09M Add
Q1 2026 385.11K $34.23M Add
Q2 2026 388.50K $36.15M Add
Q3 2026 329.27K $32.37M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BNTX and 13F data

BNTX (BIONTECH SE) is a Health Care company. 28 other funds we track also report a position in BNTX — the largest reported positions include Logos Global Management LP (US$94.4M), Davern Capital Partners, LP (US$67.1M), GSK plc (US$65.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BNTX

All BNTX fund holders →

FAQ

How long has LBP AM SA held BNTX?

LBP AM SA has disclosed BNTX holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

What is LBP AM SA's current position in BNTX?

As of Q3 2026, LBP AM SA holds 329.27K shares of BNTX (BIONTECH SE), valued at $32.37M, representing 0.29% of its reported portfolio and ranking #47.

Has LBP AM SA been buying or selling BNTX?

In the latest 13F filing (Q3 2026), LBP AM SA reduced its position in BNTX. The position peaked in Q2 2026 at 388.50K shares.

Which other funds hold BNTX?

Other major institutional holders of BNTX include Logos Global Management LP, Davern Capital Partners, LP, GSK plc, among 28 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.